A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
A number of neoplasms are known to express somatostatin receptors, and the use of somatostatin receptor imaging in their localization has recently been described. We compared an 123I-labeled somatostatin analog Tyr-3-octreotide (TOCT) and 123I-labeled metaiodobenzylguanidine (MIBG) scintigraphy in s...
Auteurs principaux: | Bomanji, J, Mather, S, Moyes, J, Ellison, D, Grossman, A, Britton, K, Besser, G |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1992
|
Documents similaires
-
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
par: Ur, E, et autres
Publié: (1993) -
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
par: Bomanji, J, et autres
Publié: (1993) -
90Y-edotreotide for metastatic carcinoid refractory to octreotide.
par: Bushnell, D, et autres
Publié: (2010) -
EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS
par: Granberg, D, et autres
Publié: (2014) -
Pituitary imaging using a labelled somatostatin analogue in acromegaly.
par: Ur, E, et autres
Publié: (1992)